Top compounds associated with response to USP17L22


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA nintedanib CTRPv2 pan-cancer AAC -0.035 0.3
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.031 0.3
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.035 0.3
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.034 0.3
mRNA alisertib CTRPv2 pan-cancer AAC -0.029 0.3
mRNA betulinic acid CTRPv2 pan-cancer AAC -0.035 0.3
mRNA regorafenib CTRPv2 pan-cancer AAC -0.034 0.3
Download CSV